Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Change in Cash (2016 - 2025)

Historic Change in Cash for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to $65.5 million.

  • Anaptysbio's Change in Cash fell 4527.81% to $65.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$81.7 million, marking a year-over-year decrease of 14945.85%. This contributed to the annual value of $87.1 million for FY2024, which is 34648.45% up from last year.
  • According to the latest figures from Q3 2025, Anaptysbio's Change in Cash is $65.5 million, which was down 4527.81% from -$54.3 million recorded in Q2 2025.
  • Over the past 5 years, Anaptysbio's Change in Cash peaked at $159.3 million during Q4 2021, and registered a low of -$329.3 million during Q1 2022.
  • For the 5-year period, Anaptysbio's Change in Cash averaged around -$7.4 million, with its median value being $9.7 million (2023).
  • In the last 5 years, Anaptysbio's Change in Cash crashed by 107743.38% in 2022 and then surged by 144395.69% in 2024.
  • Quarter analysis of 5 years shows Anaptysbio's Change in Cash stood at $159.3 million in 2021, then crashed by 91.99% to $12.8 million in 2022, then fell by 24.22% to $9.7 million in 2023, then tumbled by 808.39% to -$68.5 million in 2024, then soared by 195.67% to $65.5 million in 2025.
  • Its Change in Cash stands at $65.5 million for Q3 2025, versus -$54.3 million for Q2 2025 and -$24.4 million for Q1 2025.